Article 1 to 7 out of 7 concerning OncoMethylome Sciences S.A.
OncoMethylome Sciences Announces Licensing and Testing Agreement with Merck KGaA(06/11/2008) OncoMethylome's Technology to Be Used in Merck's Clinical Trial Program with Cilengitide OncoMethylome Sciences announced that it has signed a licensing and testing agreement with Merck KGaA of Darmstadt, Germany. Under the terms of the agreement, OncoMethylome will provide MGMT gene promoter methylation testing services for Merck's ...
OncoMethylome Sciences to Profile DNA for Abbott Oncology Compounds(12/18/2007) OncoMethylome Sciences entered into a pharmacogenomic service collaboration with Abbott. Under the terms of the collaboration, OncoMethylome will assist Abbott in profiling tumors. Specifically, OncoMethylome will be testing its DNA methylation ...
OncoMethylome Expands its Amsterdam Laboratory(03/09/2007) Colorectal Cancer Screening Program and Service Testing Capabilities Strengthened OncoMethylome Sciences announced that it has significantly expanded its Amsterdam laboratory operations. The expansion involved hiring of 10 additional scientists experienced in the field of molecular diagnostics, purchase of necessary molecular ...
OncoMethylome Sciences Expands its Collaboration with Schering-Plough(10/26/2006) OncoMethylome Sciences announced that it has entered into a new non-exclusive service agreement with Schering-Plough. Under the terms of the new agreement, OncoMethylome will receive processing fees for providing Schering-Plough with testing ...
Top
analytica
analytica China
analytica Vietnam
analytica Anacon